A comparison of the expression of PKN2 or MDH1 in AD and control subjects in this dataset revealed a significant upregulation and downregulation of PKN2 and MDH1, respectively (Figures 8H,I), which was consistent with the results of previous gene expression validation studies in AD mice. This evidence concerns the gene PKN2 and Alzheimer disease.